News
Nvidia Is Running Away With the GPU Market
Advanced Micro Devices (NASDAQ: AMD) has been a thorn in the side for Nvidia (NASDAQ: NVDA) over the past couple of years as it has made massive inroads into the latter's bread-and-butter discrete....
Can China and Italy Boost Starbucks' Slowing Growth?
Starbucks (NASDAQ: SBUX) is hoping international expansion will be the shot of caffeine that its growth story needs. The Seattle-based coffee maker reported fourth-quarter same-store sales and....
Will Alphabet Do a Stock Split in 2018?
Stock splits have become much less frequent than they were in years past, and Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) was one of the first major companies to defy the previous convention of....
2 Top Consumer Staples Stocks to Consider Buying Now -- and 1 to Avoid
Recessions are common enough that you can count on several of them impacting your portfolio over the course of even a 10-year time horizon. That's just one reason why consumer staples stocks --....
1 Dividend Stock to Buy in December
If you're looking for income from your investments in the stock market, Kroger (NYSE: KR) is a great long-term bet. Not only does it sport a meaningful dividend yield today, but Kroger's dividend....
DAX-Informationen für 07.12.2017
DAX-Informationen für 07.12.2017Prognose für die nächsten Tage/Wochen (Basis: Verwendung eines Zyklen-Systems mit optimierten Parametern): abwärts (seit 14.11.17) / Trendwende auf Schlusskursbasis
4 Things Ulta Beauty Investors Need to Know
Ulta Beauty (NASDAQ: ULTA) reported its third quarter earnings last week, and there were plenty of reasons for long-term investors to cheer. While the cosmetics industry overall saw a slowdown....
AutoZone (AZO) Q1 2018 Earnings Conference Call Transcript
Image source: The Motley Fool.AutoZone (NYSE: AZO) Q1 2018 Earnings Conference CallDec, 5, 2017 10:00 a.m. ETOperatorContinue readingSource: Fool.com
Apple's Smartphone Market Share Dipped Ahead of iPhone X Launch
Kantar Worldpanel ComTech released its latest estimates on the smartphone market yesterday, and Apple (NASDAQ: AAPL) registered notable dips in market share in a handful of important regions ahead....
How Many Model X Cars Will Tesla, Inc. Deliver This Quarter?
With sales growth of Tesla's (NASDAQ: TSLA) Model S sedan essentially coming to a halt since last year, there is growing interest in the automaker's next catalysts. Sure, the Model 3 is expected....
Intel Corp. Exec Addresses Tough Question About Modem Biz
In 2016, Apple (NASDAQ: AAPL) adopted cellular modems -- chips that handle data transmission between devices and cellular networks -- from chip giant Intel (NASDAQ: INTC) to power a portion of the....
2 Top Virtual Reality Stocks to Consider Buying
As often happens with emerging technologies, the market for virtual reality is taking much longer to develop than many people originally expected. Consider that even Facebook (NASDAQ: FB) -- which....
Disney’s Coco Is a Bigger Hit than You May Think
For the second week in a row, The Walt Disney Company's (NYSE: DIS) Coco won the weekend box office. In the U.S. and Canada, Coco topped Warner Bros' (a division of Time Warner) Justice League by....
Lululemon Athletica Builds Momentum Going Into the Holidays
It takes effort to sustain success, and lululemon athletica (NASDAQ: LULU) has learned the hard way that it takes a lot longer to build a strong reputation than to lose it. After having developed....
CVS Wants Aetna; Does Anyone Want Blue Apron?
In this Market Foolery podcast, host Chris Hill is joined by Industry Focus: Healthcare host Kristine Harjes to dissect why CVS's (NYSE: CVS) offer to purchase health insurer Aetna (NYSE: AET) for....
T-Mobile Authorizes $1.5 Billion Share Repurchase Program
Just as it promised, T-Mobile (NASDAQ: TMUS) has announced that its board of directors has authorized a new $1.5 billion share repurchase program. CFO Braxton Carter said at a conference in....
Why Tableau Software, Inc. Stock Dropped 13.3% in November
Shares of Tableau Software (NYSE: DATA) fell 13.3% in November, according to data from S&P Global Market Intelligence, after the data-visualization specialist announced weaker-than-expected....
Does It Really Matter if Supermarkets Source Produce Locally?
The irony is stark. The organic grocer that is arguably most closely identified with the local sourcing of food is moving away from the practice while the country's largest supermarket chain is....
Three Under-the-Radar Stock Picks
We talk about a lot of stocks on MarketFoolery, but there's only so much time per episode, and there are tons of great stocks that have to get swept under the podcast rug to make room for news....
Will JPMorgan Chase Do a Stock Split in 2018?
The financial sector has gone through extremely volatile times over the past 15 years. Having benefited greatly from the housing boom in the early and mid-2000s, JPMorgan Chase (NYSE: JPM) and....
November Auto Sales: Another Solid Month for the Detroit Three
Last Thursday, General Motors (NYSE: GM) detailed its strategy for surviving (and thriving) as the traditional model of car ownership is disrupted. The top U.S. automaker is confident that it can....
Why 2017 Was a Year to Remember for Phillips 66
After a somewhat lackluster 2016, this has been a much better year for Phillips 66 (NYSE: PSX). Thanks to an improvement in market conditions in the company's core refining business and the impact....
Should PayPal's Venmo Be Scared of Apple Pay Cash?
As the leader in mobile peer-to-peer (P2P) payments, PayPal's (NASDAQ: PYPL) subsidiary Venmo theoretically has the most to lose from Apple's (NASDAQ: AAPL) entry into the P2P market. The Mac....
What to Expect From TransCanada Corporation in 2018
This past year has been a good one for TransCanada (NYSE: TRP). Overall, investors have earned a more-than-11% total return since January, thanks to in large part to the groundwork it laid in....
This Double Whammy Caused Regeneron Pharmaceuticals Inc. to Fall 10% in November
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN), a large-cap biopharmaceutical company that develops treatments for eye disorders and other serious medical conditions, tumbled 10% during the....